Phase I Study of STX 64 (667 Coumate) in Breast Cancer Patients: The First Study of a Steroid Sulfatase Inhibitor

S.J. Stanway, A. Purohit, L.W.L. Woo, S. Sufi, D. Vigushin, R. Ward, Richard Wilson, F.Z. Stanczyk, N. Dobbs, E. Kulinskaya, M. Elliott, B.V.L. Potter, M.J. Reed, R.C. Coombes

Research output: Contribution to journalArticle

196 Citations (Scopus)
Original languageEnglish
Pages (from-to)1585-1592
Number of pages8
JournalClinical Cancer Research
Volume12(5)
Issue number5
DOIs
Publication statusPublished - 01 Mar 2006

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Stanway, S. J., Purohit, A., Woo, L. W. L., Sufi, S., Vigushin, D., Ward, R., Wilson, R., Stanczyk, F. Z., Dobbs, N., Kulinskaya, E., Elliott, M., Potter, B. V. L., Reed, M. J., & Coombes, R. C. (2006). Phase I Study of STX 64 (667 Coumate) in Breast Cancer Patients: The First Study of a Steroid Sulfatase Inhibitor. Clinical Cancer Research, 12(5)(5), 1585-1592. https://doi.org/10.1158/1078-0432.CCR-05-1996